Nodality, Inc., advancing the discovery, development and use of transformative therapies across broad therapeutic categories, with a focus on immunology and oncology, announced today the presentation of research findings from its collaborative partnership with UCB Pharma S.A. The data are being featured at the 2014 ACR/ARHP Annual Meeting, currently taking place in Boston, Massachusetts.
http://ift.tt/1uq7xqQ
http://ift.tt/1uq7xqQ
No comments:
Post a Comment